First COVID-19 breath test authorized for use in U.S.
The device takes three minutes to return results and has been found to be over 90 percent accurate in detecting positive COVID-19 cases.
Science & academia
New treatment helps alopecia patients regrow their hair
A new Yale study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
Stanford University researchers invent groundbreaking solar panels that work at night
The setup is inexpensive and, in principle, could be incorporated within existing solar cells. It is also simple, so construction in remote locations with limited resources is feasible.
New technique uses plastic waste to capture CO2 emissions
The scientists from Rice University developing the technique estimate that the cost to remove CO2 from flue gas streams would be about US$21 a ton, a significant improvement over existing alternatives.
Psilocybin therapy changes brain wiring in depressed people, new study finds
The new study led by researchers from Imperial College London found that people also reported a reduction in their depression symptoms alongside these brain changes.
New blood test predicts risk of heart attack and stroke with twice previous accuracy
Scientists from SomaLogic in Boulder, CO have developed a blood test that can predict whether someone is at high risk of a heart attack, stroke, heart failure within the next four years.
Brain implant allows completely “locked-in” patient to communicate
Locked-in syndrome is a rare condition that makes it impossible for the patient to move or speak, but are still conscious and can see, hear, and smell.
Climate-resilient corals offer viable options for reef restoration, new study shows
In the longest coral resilience experiment ever, researchers found that two coral species cope well with changing ocean conditions and could be used for reef restoration.
Moderna kicks off Phase 1 trial of 3 different mRNA HIV vaccines
The trial is expected to run until mid-2023. By that point it is hoped one of the three formulations will have demonstrated robust immune responses and Phase 2 trials can commence.
New cancer therapy destroys advanced ovarian and colorectal tumors in mice in 6 days
Clinical trials at Rice University are expected to begin in the next few months, after results on mice were described as “very exciting.”